Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, Luigi, Manos, Philip D., Ahfeldt, Tim, Loh, Yuin-Han, Li, Hu, Lau, Frank, Ebina, Wataru, Mandal, Pankaj K. +8 more·2010·Cell Stem Cell
DOI 10.1016/j.stem.2010.08.012

Cited by (1,006)

Items 601–700 of 1,006

  1. Self-amplifying mRNA vaccines: Mode of action, design, development and optimization
    Mohammad Mostafa Pourseif, Yosef Masoudi‐Sobhanzadeh, Erfan Azari, Sepideh Parvizpour, Jaleh Barar, Rais Ahmad Ansari, Yadollah Omidi · 2022 · Drug Discovery Today
  2. Biodegradable Lipid-Modified Poly(Guanidine Thioctic Acid)s: A Fortifier of Lipid Nanoparticles to Promote the Efficacy and Safety of mRNA Cancer Vaccines
    Kai Yang, Bing Bai, Jiaqi Lei, Xinyang Yu, Shaolong Qi, Yangfan Wang, Feihe Huang, Zaizai Tong, Guocan Yu · 2024 · Journal of the American Chemical Society
  3. Reprogramming and Carcinogenesis—Parallels and Distinctions
    Agata Magdalena Wasik, Jerzy Grabarek, Aleksandar Pantovic, Artur Cieślar‐Pobuda, Hamid Reza Asgari, Caspar Bundgaard‐Nielsen, Mehrdad Rafat, Ian Dixon, Saeid Ghavami, Marek Łoś · 2014 · International review of cytology
  4. Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability
    Xue-Mei Fu, Yang Xu · 2012 · Genome Medicine
  5. Multifaceted Regulation of Somatic Cell Reprogramming by mRNA Translational Control
    Soroush Tahmasebi, Tommy Alain, Vinagolu K. Rajasekhar, Jiang-Ping Zhang, Masha Prager‐Khoutorsky, Arkady Khoutorsky, Yildirim Dogan, Christos G. Gkogkas, Emmanuel Petroulakis, Annie Sylvestre et al. · 2014 · Cell stem cell
  6. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome
    Xiaoning Mou, Yuanbo Wu, Henghua Cao, Qingzhang Meng, Qihui Wang, Cheng‐Cao Sun, Shengshou Hu, Yue Ma, Hao Zhang · 2012 · Stem Cell Research & Therapy
  7. Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.
    Dharmendra Kumar, T. Talluri, T. Anand, Wilfried A. Kues · 2015 · World Journal of Stem Cells
  8. Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling
    Weidong Shao, Hui Xu, Kanghua Zeng, Mingzhou Ye, Renjun Pei, Kai Wang · 2025 · Stem Cell Research & Therapy
  9. Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics
    Henry Fergus Duncan, Anthony J. Smith, Garry J.P. Fleming, Paul R. Cooper · 2015 · International Endodontic Journal
  10. Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system
    Richard P. Davis, Csilla Nemes, Eszter Varga, Christian M.A.H. Freund, Georgios Kosmidis, Konstantinos Gkatzis, Daniëlle de Jong, Károly Szuhai, András Dinnyés, Christine L. Mummery · 2013 · Differentiation
  11. Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells
    Niren Murthy, Kunwoo Lee, Pengzhi Yu, Nithya Lingampalli, Hyun Jin Kim, Richard Tang · 2015 · International Journal of Nanomedicine
  12. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc
    Geertrui Tavernier, Katharina Wolfrum, Joseph Demeester, Stefaan C. De Smedt, James Adjaye, Joanna Rejman · 2011 · Biomaterials
  13. Differentiation Efficiency of Induced Pluripotent Stem Cells Depends on the Number of Reprogramming Factors
    Matthias Löhle, Andreas Hermann, Hannes Glaß, Andrea Kempe, Sigrid C. Schwarz, Jeong Beom Kim, Claire E. Poulet, Ursula Ravens, Johannes Schwarz, Hans Robert Schöler et al. · 2011 · Stem Cells
  14. Cellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal species
    Jernej Ogorevc, Sara Orehek, Peter Dovč · 2016 · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology
  15. Transient ectopic expression of the histone demethylase JMJD3 accelerates the differentiation of human pluripotent stem cells
    Tomohiko Akiyama, Shunichi Wakabayashi, Atsumi Soma, Saeko Sato, Yuhki Nakatake, Mayumi Oda, Miyako Murakami, Miki Sakota, Nana Chikazawa-Nohtomi, Shigeru B. H. Ko et al. · 2016 · Development
  16. Synthetic mRNA devices that detect endogenous proteins and distinguish mammalian cells
    Shunsuke Kawasaki, Yoshihiko Fujita, Takashi Nagaike, Kozo Tomita, Hirohide Saito · 2017 · Nucleic Acids Research
  17. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons
    Yingchao Xue, Xiping Zhan, Shisheng Sun, Senthilkumar S. Karuppagounder, Shuli Xia, Valina Lynn Dawson, Ted M. Dawson, John Laterra, Jianmin Zhang, Mingyao Ying · 2018 · Stem Cells Translational Medicine
  18. De Novo Synthesis of Elastin by Exogenous Delivery of Synthetic Modified mRNA into Skin and Elastin-Deficient Cells
    Lescan, Mario, Perl, Regine Mariette, Golombek, Sonia, Pilz, Martin, Hann, Ludmilla, Yasmin, Mahua, Behring, Andreas, Keller, Timea, Nolte, Andrea, Gruhn, Franziska et al. · 2018 · Molecular Therapy Nucleic Acids
  19. Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?
    Antje Ebert, Sebastian Diecke, Ian Y. Chen, Joseph C. Wu · 2015 · EMBO Molecular Medicine
  20. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells
    Mohammed Kawser Hossain, Ahmed Abdal Dayem, Jihae Han, Subbroto Kumar Saha, Gwangmo Yang, H. Choi, Ssang-goo Cho · 2016 · International Journal of Molecular Sciences
  21. Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signaling-directed lineage conversion
    Saiyong Zhu, Haixia Wang, Sheng Ding · 2015 · Nature Protocols
  22. Induced pluripotent stem cells as a source of hepatocytes
    V. Sauer, N. Roy-Chowdhury, C. Guha, J. Roy-Chowdhury · 2014 · Current Pathobiology Reports
  23. X-Chromosome Inactivation in Rett Syndrome Human Induced Pluripotent Stem Cells
    Aaron Y. L. Cheung, Lindsay M. Horvath, Laura Carrel, James Ellis · 2012 · Frontiers in Psychiatry
  24. Reversibility of irreversible aging
    Fedor Galkin, Bohan Zhang, Sergey E. Dmitriev, Vadim N. Gladyshev · 2018 · Ageing Research Reviews
  25. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells
    A. Ray, J. Joshi, P. K. Sundaravadivelu, Khyati Raina, N. Lenka, Vishwas Kaveeshwar, Rajkumar P. Thummer · 2021 · Stem Cell Reviews and Reports
  26. The transcriptional regulator ZNF398 mediates pluripotency and epithelial character downstream of TGF-beta in human PSCs
    Irene Zorzan, Marco Pellegrini, Mattia Arboit, Danny Incarnato, Mara Maldotti, Mattia Forcato, Guidantonio Malagoli Tagliazucchi, Elena Carbognin, Marco Montagner, Salvatore Oliviero et al. · 2020 · Nature Communications
  27. Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
    Thijs Van de Vyver, Stefaan C. De Smedt, Koen Raemdonck · 2021 · Advanced Drug Delivery Reviews
  28. Transitions between epithelial and mesenchymal states during cell fate conversions
    Xiang Li, Duanqing Pei, Hui Zheng · 2014 · Protein & Cell
  29. Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression
    Meltem Avci‐Adali, Andreas Behring, Timea Keller, Stefanie Krajewski, Christian Schlensak, Hans Peter Wendel · 2014 · Journal of Biological Engineering
  30. Forward engineering neuronal diversity using direct reprogramming
    Rachel K. Tsunemoto, Kevin Eade, Joel Blanchard, Kristin K. Baldwin · 2015 · The EMBO Journal
  31. Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells
    Jun Li, Wei Song, Guangjin Pan, Jun Zhou · 2014 · Journal of Hematology & Oncology
  32. A bibliometric analysis of publications on pluripotent stem cell research.
    Changshuan L. Lin, Yuh‐Shan Ho · 2015 · PubMed Central
  33. Targeting LRRK2 in Parkinson’s disease: an update on recent developments
    Sharon L. Chan, Eng‐King Tan · 2017 · Expert Opinion on Therapeutic Targets
  34. Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods
    Jared M. Churko, Jaecheol Lee, Mohamed Ameen, Mingxia Gu, Meenakshi Venkatasubramanian, Sebastian Diecke, Karim Sallam, Hogune Im, Gavin Wang, Joseph D. Gold et al. · 2017 · Nature Biomedical Engineering
  35. iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies
    Jose L Ortiz-Vitali, Radbod Darabi · 2019 · Cells
  36. Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector
    Khan, Majad, Narayanan, Karthikeyan, Lu, Hongfang, Choo, Yang, Du, Chan, Wiradharma, Nikken, Yang, Yi-Yan, Wan, Andrew C.A. · 2013 · Biomaterials
  37. Optimized Mitochondrial Targeting of Proteins Encoded by Modified mRNAs Rescues Cells Harboring Mutations in mtATP6
    Chin, Randall Marcelo, Panavas, Tadas, Brown, Jeffrey M., Johnson, Krista K. · 2018 · Cell Reports
  38. How induced pluripotent stem cells are redefining personalized medicine
    Leonardo M. R. Ferreira, Mohammed A. Mostajo-Radji · 2013 · Gene
  39. Deciphering the epitranscriptome: A green perspective
    Alice Burgess, Rakesh David, Iain Robert Searle · 2016 · Journal of Integrative Plant Biology
  40. Transcriptome asymmetry within mouse zygotes but not between early embryonic sister blastomeres
    Matthew David VerMilyea, Matthias Maneck, Naoko Yoshida, Isabell Blochberger, Emi Suzuki, Toru Suzuki, Rainer Spang, Christoph A. Klein, Anthony C.F. Perry · 2011 · The EMBO Journal
  41. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
    Atsushi Tanaka, Shinsuke Yuasa, Koichi Node, Keiichi Fukuda · 2015 · International Journal of Molecular Sciences
  42. Making β Cells from Adult Cells Within the Pancreas
    Philippe Antoine Lysy, Gordon C. Weir, Susan Bonner‐Weir · 2013 · Current Diabetes Reports
  43. Non-Viral Generation of Marmoset Monkey iPS Cells by a Six-Factor-in-One-Vector Approach
    Katharina Debowski, Rita Warthemann, Jana Lentes, Gabriela Salinas, Ralf Dressel, Daniel Langenstroth, Jörg Gromoll, Erika Sasaki, Rüdiger Behr · 2015 · PLoS ONE
  44. Differential Effects of Epigenetic Modifiers on the Expansion and Maintenance of Human Cord Blood Stem/Progenitor Cells
    Nadim Mahmud, Benjamin J. Petro, Sudhakar Baluchamy, Xinmin Li, Simona Taioli, Donald Lavelle, John G. Quigley, Montha Suphangul, Hiroto Araki · 2014 · Transplantation and Cellular Therapy
  45. Rapid and Efficient Conversion of Integration-Free Human Induced Pluripotent Stem Cells to GMP-Grade Culture Conditions
    Jens Durruthy-Durruthy, Sharon F. Briggs, Jason P. Awe, Cyril Y. Ramathal, Saravanan Karumbayaram, Patrick C. Lee, Julia D. Heidmann, Amander T. Clark, Ioannis Karakikes, Kyle M. Loh et al. · 2014 · PLoS ONE
  46. Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review
    Oliwia Andries, Tasuku Kitada, Katie Bodner, Niek N. Sanders, Ron Weiss · 2015 · Expert Review of Vaccines
  47. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
    Siddharth Menon, Siny Shailendra, Andrea Renda, Michael Thornton Longaker, Natalina Quarto · 2016 · International Journal of Molecular Sciences
  48. Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors
    Fusako Sakai‐Takemura, Asako Narita, Satoru Masuda, Toshifumi Wakamatsu, Nobuharu Watanabe, Takashi Nishiyama, Kenichiro Nogami, Matthias Blanc, Shin’ichi Takeda, Yuko Miyagoe‐Suzuki · 2018 · Scientific Reports
  49. Neural Regeneration
    Melissa Steward, Akshayalakshmi Sridhar, Jason S. Meyer · 2012 · Current topics in microbiology and immunology
  50. Messenger RNA-Based Therapeutics and Vaccines: What’s beyond COVID-19?
    Dongqiao Li, Cynthia Liu, Yingzhu Li, Rumiana Tenchov, Janet M. Sasso, Di Zhang, Dan Li, Lixue Zou, Xuezhao Wang, Qiongqiong Angela Zhou · 2023 · ACS Pharmacology & Translational Science
  51. Drug Discovery Models and Toxicity Testing Using Embryonic and Induced Pluripotent Stem-Cell-Derived Cardiac and Neuronal Cells
    Rahul S. Deshmukh, Krisztián A. Kovács, András Dinnyés · 2012 · Stem Cells International
  52. Induced pluripotent stem cells: A new tool to confront the challenge of neuropsychiatric disorders
    Flora Maria Vaccarino, Hanna Elizabeth Stevens, Arif Murat Kocabas, Dean Palejev, Anna M. Szekely, Elena L. Grigorenko, Sherman M. Weissman · 2011 · Neuropharmacology
  53. Human Pluripotent Stem Cell-Based Approaches for Myocardial Repair: From the Electrophysiological Perspective
    Ellen Ngar-Yun Poon, Chi‐Wing Kong, Ronald A. Li · 2011 · Molecular Pharmaceutics
  54. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation
    Christine Cheung, Sanjay Sinha · 2011 · Journal of Molecular and Cellular Cardiology
  55. The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders
    Graham D. Cocks, Sarah R Curran, Priya Gami‐Patel, Dafe Uwanogho, Aaron R. Jeffries, Annie Kathuria, Walter Lucchesi, Victoria H. J. Wood, Rosemary Dixon, Caroline Mackie Ogilvie et al. · 2013 · Psychopharmacology
  56. Pluripotent Stem Cell–Derived Hepatocytes: Potential and Challenges in Pharmacology
    Dagmara Szkolnicka, Wenli Zhou, Baltasar Lucendo‐Villarin, David C. Hay · 2013 · The Annual Review of Pharmacology and Toxicology
  57. Translating the epitranscriptome
    Thomas Philipp Hoernes, Matthias David Erlacher · 2016 · Wiley Interdisciplinary Reviews - RNA
  58. Human neural progenitors derived from integration-free iPSCs for SCI therapy
    Ying Liu, Yiyan Zheng, Shenglan Li, Haipeng Xue, Karl Schmitt, Georgene W. Hergenroeder, Jiaqian Wu, Yuanyuan Zhang, Dong Kim, Qilin Cao · 2017 · Stem Cell Research
  59. Pluripotent stem cells to hepatocytes, the journey so far
    Anwar Azad Palakkan, Jyoti Nanda, James A. Ross · 2017 · Biomedical Reports
  60. Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine
    Sayali Mukherjee, Garima Yadav, Rajnish Kumar · 2021 · World Journal of Stem Cells
  61. The Combination of Tet1 with Oct4 Generates High-Quality Mouse-Induced Pluripotent Stem Cells
    Jiayu Chen, Yawei Gao, Hua Huang, Kai Xu, Xia Chen, Yonghua Jiang, Hui Li, Shuai Gao, Yu Tao, Hong Wang et al. · 2014 · Stem Cells
  62. iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls
    Daria Prilutsky, Nathan Palmer, Niklas Smedemark-Margulies, Thorsten M. Schlaeger, David M. Margulies, Isaac S. Kohane · 2013 · Trends in Molecular Medicine
  63. Cellular Reprogramming Employing Recombinant Sox2 Protein
    Marc Christian Thier, Bernhard Münst, Stephanie Mielke, Frank Edenhofer · 2012 · Stem Cells International
  64. Functional Multipotency of Stem Cells: A Conceptual Review of Neurotrophic Factor-Based Evidence and Its Role in Translational Research
    Dae Yul Yang, Dou Yu, Dou Dou, Ropper, Alexander E, Li, Jianxue, Serdar Kabataş, Serdar, Wakeman et al. · 2011 · Current Neuropharmacology
  65. Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status
    Jason P. Awe, Patrick C. Lee, Cyril Y. Ramathal, Agustin Vega-Crespo, Jens Durruthy-Durruthy, Aaron R. Cooper, Saravanan Karumbayaram, William E. Lowry, Amander T. Clark, Jerome A. Zack et al. · 2013 · Stem Cell Research & Therapy
  66. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation
    Daekee Kwon, Jin‐Su Kim, Byung-Hyun Cha, Kwang‐Sook Park, Inbo Han, Kyung‐Soon Park, Hojae Bae, Myung‐Kwan Han, Kwang‐Soo Kim, Soo‐Hong Lee · 2016 · Cell Transplantation
  67. Stem Cell Therapies for Treatment of Liver Disease
    Clara T. Nicolas, Yujia Wang, Jennifer L. Luebke-Wheeler, Scott L. Nyberg · 2016 · Biomedicines
  68. Pluripotent stem cells and livestock genetic engineering
    Delia Alba Soto, Pablo J. Ross · 2016 · Transgenic Research
  69. Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury
    Vanessa M. Doulames, G. Plant · 2016 · International Journal of Molecular Sciences
  70. Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells
    Brad J. Dykstra, Jungmin Lee, Luke J. Mortensen, Haixiao Yu, Zhengliang L. Wu, Charles P. Lin, Derrick J. Rossi, Robert Sackstein · 2016 · Stem Cells
  71. Cellular Reprogramming Using Protein and Cell-Penetrating Peptides
    Bong Jong Seo, Yean Ju Hong, Jeong Do · 2017 · International Journal of Molecular Sciences
  72. Protein-driven RNA nanostructured devices that function in vitro and control mammalian cell fate
    T. Shibata, Yoshihiko Fujita, Hirohisa Ohno, Yuki Suzuki, Karin Hayashi, Kaoru R. Komatsu, Shunsuke Kawasaki, Kumi Hidaka, Shin Yonehara, Hiroshi Sugiyama et al. · 2017 · Nature Communications
  73. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus
    Huahu Ye, Qiwei Wang · 2018 · Cellular Physiology and Biochemistry
  74. Microfluidic reprogramming to pluripotency of human somatic cells
    Onelia Gagliano, Camilla Luni, Wei Qin, Enrica Bertin, Erika Torchio, Silvia Galvanin, Anna Urciuolo, Nicola Elvassore · 2019 · Nature Protocols
  75. Tissue Engineering in Pediatric Bladder Reconstruction—The Road to Success
    Maya Horst, Daniel Eberli, Rita Gobet, Souzan Salemi · 2019 · Frontiers in Pediatrics
  76. Latest Advances for the Sleeping Beauty Transposon System: 23 Years of Insomnia but Prettier than Ever
    Maximilian Amberger, Zoltán Ivics · 2020 · BioEssays
  77. Differentiation of Human Induced Pluripotent Stem Cells into a Keratinocyte Lineage
    Igor Kogut, Dennis R. Roop, Ganna Bilousova · 2013 · Methods in molecular biology
  78. The StemCellFactory: A Modular System Integration for Automated Generation and Expansion of Human Induced Pluripotent Stem Cells
    Elanzew, Andreas, Nießing, Bastian, Langendoerfer, Daniel, Rippel, Oliver, Piotrowski, Tobias, Schenk, Friedrich, Kulik, Michael, Peitz, Michael, Breitkreuz, Yannik, Jung, Sven et al. · 2020 · Frontiers in Bioengineering and Biotechnology
  79. The evolving biology of cell reprogramming
    I. Wilmut, G. Sullivan, I. Chambers · 2011 · Philosophical Transactions of the Royal Society B: Biological Sciences
  80. Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood
    Haihui Gu, Xia Huang, Jing Xu, Lili Song, Shuping Liu, Xiao‐Bing Zhang, Weiping Yuan, Yanxin Li · 2018 · Stem Cell Research & Therapy
  81. Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering
    A. Shukla, Ge Gao, B. Kim · 2022 · Micromachines
  82. Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood–Derived Cells
    Pauline Damien, David Allan · 2015 · Transplantation and Cellular Therapy
  83. Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells
    Chunbo Yang, Jumana Yousuf Al-Aama, Miodrag Stojković, Bernard D. Keavney, Andrew W. Trafford, Majlinda Lako, Lyle Armstrong · 2015 · Stem Cells
  84. Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection
    Hyo Young Park, Eun Hyung Noh, Hyung‐Min Chung, Man‐Jong Kang, Eun Young Kim, Se‐Pill Park · 2012 · PLoS ONE
  85. Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia
    Seth P. Boudreaux, Ashley M. Ramirez-Herrick, Ryan P. Duren, Orla M. Conneely · 2012 · Oncogenesis
  86. Synthetic mRNAs for manipulating cellular phenotypes: an overview
    Elgar Susanne Quabius, Guido Krupp · 2014 · New Biotechnology
  87. Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers
    Daniel Gallego‐Perez, José Javier Otero, Catherine Miriam Czeisler, Jun‐Yu Ma, Cristina Ortiz, Patrick Edwin Gygli, Fay Patsy Catacutan, Hamza Numan Gokozan, Aaron Cowgill, Thomas W. Sherwood et al. · 2015 · Nanomedicine Nanotechnology Biology and Medicine
  88. Modificaomics: deciphering the functions of biomolecule modifications
    Ting Liu, Cheng-Jie Ma, Bi‐Feng Yuan, Yu‐Qi Feng · 2018 · Science China Chemistry
  89. Urine-derived cells provide a readily accessible cell type for feeder-free mRNA reprogramming
    Anne Gaignerie, Nathalie Lefort, Morgane Rousselle, Virginie F Forest, Léa Flippe, Valentin François-Campion, Aurore Girardeau, Amandine Caillaud, Caroline Chariau, Quentin Francheteau et al. · 2018 · Scientific Reports
  90. Sumoylation of Krüppel-like Factor 4 Inhibits Pluripotency Induction but Promotes Adipocyte Differentiation
    Soroush Tahmasebi, Mohammad Ghorbani, Paul Savage, Kezhi Yan, Goran Gocevski, Lin Xiao, Linya You, Xiang‐Jiao Yang · 2013 · Journal of Biological Chemistry
  91. Proneural Transcription Factor Atoh1 Drives Highly Efficient Differentiation of Human Pluripotent Stem Cells Into Dopaminergic Neurons
    Jonathan Sagal, Xiping Zhan, Jinchong Xu, Jessica I. Tilghman, Senthilkumar S. Karuppagounder, Li Chen, Valina Lynn Dawson, Ted M. Dawson, John Laterra, Mingyao Ying · 2014 · Stem Cells Translational Medicine
  92. Human Amniotic Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells May Generate a Universal Source of Cardiac Cells
    Xiaohu Ge, I‐Ning E. Wang, Ildikó Toma, Vittorio Sebastiano, Jianwei Liu, Manish J. Butte, Renee A. Reijo Pera, Phillip Chung-Ming Yang · 2012 · Stem Cells and Development
  93. Improved differentiation of umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells by PDX-1 mRNA transfection
    Phuc Van Pham, Phuoc Thi-My Nguyen, Anh Thai-Quynh Nguyen, Vuong Minh Pham, Anh Nguyen-Tu Bui, Loan Thi-Tung Dang, Khue Gia Nguyen, Ngoc Kim Phan · 2014 · Differentiation
  94. The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts
    Katharina Drews, Geertrui Tavernier, Joseph Demeester, Hans Rudolf Lehrach, Stefaan C. De Smedt, Joanna Rejman, James Adjaye · 2012 · Biomaterials
  95. Inactivation of the p53–KLF4–CEBPA Axis in Acute Myeloid Leukemia
    Katja Seipel, Miguel Teixera Marques, Marie-Ange Bozzini, Christina Meinken, Beatrice U. Mueller, Thomas Pabst · 2015 · Clinical Cancer Research
  96. THERAPY OF ENDOCRINE DISEASE: Islet transplantation for type 1 diabetes: so close and yet so far away
    Mohsen Khosravi Maharlooei, Ensiyeh Hajizadeh‐Saffar, Yaser Tahamtani, Mohsen Basiri, Leila Montazeri, Keynoosh Khalooghi, Mohammad Kazemi Ashtiani, Ali Farrokhi, Nasser Aghdami, Anavasadat Sadr Hashemi Nejad et al. · 2015 · European Journal of Endocrinology
  97. Apoptosis and failure of checkpoint kinase 1 activation in human induced pluripotent stem cells under replication stress
    Joëlle A. Desmarais, Christian A. Unger, Ivan Damjanov, Mark Meuth, Peter W. Andrews · 2016 · Stem Cell Research & Therapy
  98. Biomaterials control of pluripotent stem cell fate for regenerative therapy
    Román A. Pérez, Seong‐Jun Choi, Cheol‐Min Han, Jung‐Ju Kim, Hosup Shim, Kam W. Leong, Hae‐Won Kim · 2016 · Progress in Materials Science
  99. Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts
    Ferizi, Mehrije, Aneja, Manish K., Balmayor, Elizabeth R., Badieyan, Zohreh Sadat, Mykhaylyk, Olga, Rudolph, Carsten, Plank, Christian · 2016 · Scientific Reports
  100. The expanding horizon of MicroRNAs in cellular reprogramming
    Yogita K. Adlakha, Pankaj Seth · 2016 · Progress in Neurobiology